In addition, BCAM overexpression has previously been described in epithelial skin tumors [9], [10], [28], ovarian cancer [29], pancreatic cancer [30], and hepatocellular carcinoma [11]. This evidence concerns the gene BCAM and familial pancreatic carcinoma.